Progestogen Options +/- Estrogen Formulations

Vocabulary practice flashcards covering trade names, active components, routes, dosing schedules, and clinical considerations for progestogen and estrogen hormone therapy options.

Prometrium

An oral micronized progesterone medication dosed at $100\,\text{mg}$ nightly (continuous) or $200\,\text{mg}$ nightly for $12\text{--}14\,\text{days}$ per month.

Activella, Amabelz, Mimvey

Oral combination products consisting of estradiol ($E_2$) and norethindrone acetate, dosed at $0.5/0.1\,\text{mg}$ or $1/0.5\,\text{mg}$ QD.

Angeliq

An oral combination product containing estradiol ($E_2$) and drospirenone, administered at a dosage of $0.5/0.25\,\text{mg}$ or $1/0.5\,\text{mg}$ QD.

Bijuva

An oral combination product containing estradiol ($E_2$) and progesterone, administered at a dosage of $1/100\,\text{mg}$ QD.

Fyavolv

An oral combination product of ethinyl estradiol (ethinyl $E_2$) and norethindrone acetate, dosed at $0.0025/0.5\,\text{mg}$ or $0.005/1\,\text{mg}$ QD.

Jinteli

An oral combination product of ethinyl estradiol (ethinyl $E_2$) and norethindrone acetate, administered at a dose of $0.005/1\,\text{mg}$ QD.

Prefest

An oral combination formulation composed of estradiol ($E_2$) and norgestimate, dosed at $1/0.09\,\text{mg}$ QD.

Premphase

An oral combination formulation containing estradiol ($E_2$) and medroxyprogesterone, dosed at $0.625/5\,\text{mg}$ QD in a $28\text{-day}$ sequence.

Climara Pro

A transdermal system containing estradiol ($E_2$) and levonorgestrel, administered at a dose of $0.045/0.015\,\text{mg}$ once weekly (QW).

Combipatch

A transdermal patch containing estradiol ($E_2$) and norethindrone acetate, administered at $0.05/0.14\,\text{mg}$ to $0.05/0.25\,\text{mg}$ twice weekly.

Transdermal Hormone Therapy (HT)

A route of hormone therapy administration associated with possibly lower risk of VTE (venous thromboembolism) than oral HT, which may be safer for women with risk factors for CVD (cardiovascular disease).